[Hartnup syndrome. I. Diagnosis, therapy and clinical course].
D000293:Adolescent; D002524:Cerebellar Ataxia / Q000209:etiology; D003937:Diagnosis, Differential; D004044:Dietary Proteins; D004569:Electroencephalography; D006250:Hartnup Disease / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D008286:Malabsorption Syndromes / Q000209:etiology; D009129:Muscle Tonus; D009355:Neomycin / Q000627:therapeutic use; D009461:Neurologic Manifestations; D009536:Niacinamide / Q000627:therapeutic use; D010787:Photosensitivity Disorders / Q000209:etiology; D011618:Psychotic Disorders / Q000209:etiology; D011736:Pyridoxine / Q000627:therapeutic use
D004044:Dietary Proteins; D009536:Niacinamide; D009355:Neomycin; D011736:Pyridoxine
Das Hartnup-Syndrom. I. Diagnose, Therapie und klinischer Verlauf.